India Neurological Biomarkers Market (2025-2031) | Analysis, Industry, Share, Companies, Forecast, Competitive Landscape, Outlook, Segmentation, Growth, Size & Revenue, Value, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Neurological Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 India Neurological Biomarkers Market - Industry Life Cycle

3.4 India Neurological Biomarkers Market - Porter's Five Forces

3.5 India Neurological Biomarkers Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 India Neurological Biomarkers Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 India Neurological Biomarkers Market Revenues & Volume Share, By End Use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of neurological disorders in India

4.2.2 Technological advancements in biomarker research and development

4.2.3 Growing awareness and focus on early disease detection and personalized medicine

4.3 Market Restraints

4.3.1 High costs associated with biomarker research and development

4.3.2 Regulatory challenges and stringent approval processes

4.3.3 Limited availability of skilled professionals in biomarker analysis

6.1 India Neurological Biomarkers Market, By Type

6.1.1 Overview and Analysis

6.1.2 India Neurological Biomarkers Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 India Neurological Biomarkers Market Revenues & Volume, By Genomic Biomarkers, 2021- 2031F

6.1.4 India Neurological Biomarkers Market Revenues & Volume, By Proteomic Biomarkers, 2021- 2031F

6.1.5 India Neurological Biomarkers Market Revenues & Volume, By Metabolomic Biomarkers, 2021- 2031F

6.1.6 India Neurological Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F

6.1.7 India Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 India Neurological Biomarkers Market, By Application

6.2.1 Overview and Analysis

6.2.2 India Neurological Biomarkers Market Revenues & Volume, By Alzheimer's Disease, 2021- 2031F

6.2.3 India Neurological Biomarkers Market Revenues & Volume, By Parkinson's Disease, 2021- 2031F

6.2.4 India Neurological Biomarkers Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F

6.2.5 India Neurological Biomarkers Market Revenues & Volume, By Autism Spectrum Disorders, 2021- 2031F

6.2.6 India Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.3 India Neurological Biomarkers Market, By End Use

6.3.1 Overview and Analysis

6.3.2 India Neurological Biomarkers Market Revenues & Volume, By Hospital Laboratories, 2021- 2031F

6.3.3 India Neurological Biomarkers Market Revenues & Volume, By Clinical Diagnostic Centers, 2021- 2031F

6.3.4 India Neurological Biomarkers Market Revenues & Volume, By Research Organizations, 2021- 2031F

6.3.5 India Neurological Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Neurological Biomarkers Market Export to Major Countries

7.2 India Neurological Biomarkers Market Imports from Major Countries

8.1 Number of clinical trials incorporating neurological biomarkers in India

8.2 Adoption rate of neurological biomarker testing in healthcare facilities

8.3 Investments in research and development of neurological biomarkers in India

9.1 India Neurological Biomarkers Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 India Neurological Biomarkers Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 India Neurological Biomarkers Market Opportunity Assessment, By End Use, 2021 & 2031F

10.1 India Neurological Biomarkers Market Revenue Share, By Companies, 2024

10.2 India Neurological Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters